
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Bladder cancer, inflammageing and microbiomes
Austin Martin, Benjamin L. Woolbright, Shahid Umar, et al.
Nature Reviews Urology (2022) Vol. 19, Iss. 8, pp. 495-509
Closed Access | Times Cited: 51
Austin Martin, Benjamin L. Woolbright, Shahid Umar, et al.
Nature Reviews Urology (2022) Vol. 19, Iss. 8, pp. 495-509
Closed Access | Times Cited: 51
Showing 1-25 of 51 citing articles:
Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors
Ibrahim Jubber, Sean Ong, Laura Bukavina, et al.
European Urology (2023) Vol. 84, Iss. 2, pp. 176-190
Open Access | Times Cited: 215
Ibrahim Jubber, Sean Ong, Laura Bukavina, et al.
European Urology (2023) Vol. 84, Iss. 2, pp. 176-190
Open Access | Times Cited: 215
Bladder cancer
Lars Dyrskjøt, Donna E. Hansel, Jason A. Efstathiou, et al.
Nature Reviews Disease Primers (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 163
Lars Dyrskjøt, Donna E. Hansel, Jason A. Efstathiou, et al.
Nature Reviews Disease Primers (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 163
Short-chain fatty acids in cancer pathogenesis
Mark A. Feitelson, Alla Arzumanyan, Arvin Medhat, et al.
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 3, pp. 677-698
Open Access | Times Cited: 47
Mark A. Feitelson, Alla Arzumanyan, Arvin Medhat, et al.
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 3, pp. 677-698
Open Access | Times Cited: 47
JAM3: A prognostic biomarker for bladder cancer via epithelial–mesenchymal transition regulation
Zhong-Qi Pang, Jianshe Wang, Jin‐feng Wang, et al.
Biomolecules and Biomedicine (2024) Vol. 24, Iss. 4, pp. 897-911
Open Access | Times Cited: 22
Zhong-Qi Pang, Jianshe Wang, Jin‐feng Wang, et al.
Biomolecules and Biomedicine (2024) Vol. 24, Iss. 4, pp. 897-911
Open Access | Times Cited: 22
Exosomal circRNAs: Novel biomarkers and therapeutic targets for urinary tumors
Qiang Liu, Shenglong Li
Cancer Letters (2024) Vol. 588, pp. 216759-216759
Closed Access | Times Cited: 18
Qiang Liu, Shenglong Li
Cancer Letters (2024) Vol. 588, pp. 216759-216759
Closed Access | Times Cited: 18
Molecular crosstalk between polyphenols and gut microbiota in cancer prevention
Falak Zeb, Huma Naqeeb, Tareq M. Osaili, et al.
Nutrition Research (2024) Vol. 124, pp. 21-42
Closed Access | Times Cited: 16
Falak Zeb, Huma Naqeeb, Tareq M. Osaili, et al.
Nutrition Research (2024) Vol. 124, pp. 21-42
Closed Access | Times Cited: 16
Anticancer Effects of Gut Microbiota-Derived Short-Chain Fatty Acids in Cancers
Mi‐Young Son, Hyun‐Soo Cho
Journal of Microbiology and Biotechnology (2023) Vol. 33, Iss. 7, pp. 849-856
Open Access | Times Cited: 35
Mi‐Young Son, Hyun‐Soo Cho
Journal of Microbiology and Biotechnology (2023) Vol. 33, Iss. 7, pp. 849-856
Open Access | Times Cited: 35
Mild magnetic hyperthermia-activated immuno-responses for primary bladder cancer therapy
Fenggang Qi, Qunqun Bao, Ping Hu, et al.
Biomaterials (2024) Vol. 307, pp. 122514-122514
Closed Access | Times Cited: 11
Fenggang Qi, Qunqun Bao, Ping Hu, et al.
Biomaterials (2024) Vol. 307, pp. 122514-122514
Closed Access | Times Cited: 11
Association of Age with Non–muscle-invasive Bladder Cancer: Unearthing a Biological Basis for Epidemiological Disparities?
Niyati Lobo, Zhigang Duan, Anil K. Sood, et al.
European Urology Oncology (2024) Vol. 7, Iss. 5, pp. 1069-1079
Open Access | Times Cited: 10
Niyati Lobo, Zhigang Duan, Anil K. Sood, et al.
European Urology Oncology (2024) Vol. 7, Iss. 5, pp. 1069-1079
Open Access | Times Cited: 10
Causal associations between gut microbiota and urological tumors: a two-sample mendelian randomization study
Mingdong Wang, Xiang Gao, Quan Yongjun, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 18
Mingdong Wang, Xiang Gao, Quan Yongjun, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 18
Preclinical models of bladder cancer: BBN and beyond
David Matye, Juliann Leak, Benjamin L. Woolbright, et al.
Nature Reviews Urology (2024) Vol. 21, Iss. 12, pp. 723-734
Closed Access | Times Cited: 7
David Matye, Juliann Leak, Benjamin L. Woolbright, et al.
Nature Reviews Urology (2024) Vol. 21, Iss. 12, pp. 723-734
Closed Access | Times Cited: 7
The Role of Tumor and Host Microbiome on Immunotherapy Response in Urologic Cancers
Jake Drobner, Krishna Doppalapudi, Biren Saraiya, et al.
Journal of Cancer Immunology (2024) Vol. 6, Iss. 1, pp. 1-13
Open Access | Times Cited: 5
Jake Drobner, Krishna Doppalapudi, Biren Saraiya, et al.
Journal of Cancer Immunology (2024) Vol. 6, Iss. 1, pp. 1-13
Open Access | Times Cited: 5
Synergistic Interactions Between Probiotics and Anticancer Drugs: Mechanisms, Benefits, and Challenges
Babak Pezeshki, Hussein T. Abdulabbas, Asma M. Alturki, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access
Babak Pezeshki, Hussein T. Abdulabbas, Asma M. Alturki, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access
Senescence-specific molecular subtypes stratify the hallmarks of the tumor microenvironment and guide precision medicine in bladder cancer
Luzhe Yan, Haisu Liang, Tiezheng Qi, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Luzhe Yan, Haisu Liang, Tiezheng Qi, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Association of metabolic syndrome and chronic kidney disease with nonmuscle invasive bladder cancer recurrence and progression
Christabel Egemba, Sasha Kapil, Tarek Ajami, et al.
Urologic Oncology Seminars and Original Investigations (2025)
Closed Access
Christabel Egemba, Sasha Kapil, Tarek Ajami, et al.
Urologic Oncology Seminars and Original Investigations (2025)
Closed Access
Adaptive Immunity in Genitourinary Cancers
Madhuri Koti, Trinity J. Bivalacqua, Peter C. Black, et al.
European Urology Oncology (2023) Vol. 6, Iss. 3, pp. 263-272
Open Access | Times Cited: 11
Madhuri Koti, Trinity J. Bivalacqua, Peter C. Black, et al.
European Urology Oncology (2023) Vol. 6, Iss. 3, pp. 263-272
Open Access | Times Cited: 11
Bacterial infection and microbiota in carcinogenesis and tumor development
Qiao Li
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 11
Qiao Li
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 11
Host-microbe-cancer interactions on-a-chip
Mauricio G. C. Sousa, Danielle S.K. Brasino, Madeline Krieger, et al.
Frontiers in Bioengineering and Biotechnology (2025) Vol. 13
Open Access
Mauricio G. C. Sousa, Danielle S.K. Brasino, Madeline Krieger, et al.
Frontiers in Bioengineering and Biotechnology (2025) Vol. 13
Open Access
Recent development of urinary biomarkers for bladder cancer diagnosis and monitoring
Yuchen Zeng, Anqi Wang, Wei Lv, et al.
Clinical and Translational Discovery (2023) Vol. 3, Iss. 2
Open Access | Times Cited: 10
Yuchen Zeng, Anqi Wang, Wei Lv, et al.
Clinical and Translational Discovery (2023) Vol. 3, Iss. 2
Open Access | Times Cited: 10
The Interplay between Microbiota and Chemotherapy-Derived Metabolites in Breast Cancer
Julio Plaza‐Díaz, Ana I. Álvarez‐Mercado
Metabolites (2023) Vol. 13, Iss. 6, pp. 703-703
Open Access | Times Cited: 10
Julio Plaza‐Díaz, Ana I. Álvarez‐Mercado
Metabolites (2023) Vol. 13, Iss. 6, pp. 703-703
Open Access | Times Cited: 10
Urinary microbiome dysbiosis is associated with an inflammatory environment and perturbed fatty acids metabolism in the pathogenesis of bladder cancer
Cen Wu, Xiaoyu Wei, Zhiyang Huang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Cen Wu, Xiaoyu Wei, Zhiyang Huang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
The Oncobiome in Gastroenteric and Genitourinary Cancers
Domenica Lucia D’Antonio, Simona Marchetti, Pamela Pignatelli, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9664-9664
Open Access | Times Cited: 15
Domenica Lucia D’Antonio, Simona Marchetti, Pamela Pignatelli, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9664-9664
Open Access | Times Cited: 15
Integrated Analysis of the Fecal Metagenome and Metabolome in Bladder Cancer in a Chinese Population
Chuan Qin, Zhenghao Chen, Rui Cao, et al.
Genes (2022) Vol. 13, Iss. 11, pp. 1967-1967
Open Access | Times Cited: 15
Chuan Qin, Zhenghao Chen, Rui Cao, et al.
Genes (2022) Vol. 13, Iss. 11, pp. 1967-1967
Open Access | Times Cited: 15
Recurrent Bacteriuria as a Prognosis Marker in the Adjuvant Treatment of Non-Muscle Invasive Bladder Cancer
J.J. Szczesniewski, Magaly-Teresa Márquez-Sánchez, Bárbara Padilla‐Fernández, et al.
Clinical Genitourinary Cancer (2024) Vol. 22, Iss. 3, pp. 102048-102048
Open Access | Times Cited: 2
J.J. Szczesniewski, Magaly-Teresa Márquez-Sánchez, Bárbara Padilla‐Fernández, et al.
Clinical Genitourinary Cancer (2024) Vol. 22, Iss. 3, pp. 102048-102048
Open Access | Times Cited: 2
Network Pharmacology Combined with Bioinformatics Analysis to Texplore the Potential Mechanism of Phellodendri Chinensis Cortex Against Bladder Cancer
Lili Hu, Na Wu, Jue Wang, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 4, pp. 3317-3331
Closed Access | Times Cited: 2
Lili Hu, Na Wu, Jue Wang, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 4, pp. 3317-3331
Closed Access | Times Cited: 2